glp-1 for bulimia While blockbuster drugs like Wegovy and Zepbound are known helping people lose weight, a new wave of people are using them to treat their eating disorders instead. Success, for them GLP-1 RAs in Eating Disorders:

In contrast, Goel et al., in a retrospective population-based cohort study of patients undergoing elective surgery, reported that active cannabis use disorder was associated with a significantly higher risk of postoperative myocardial infarction, with an adjusted odds ratio of 1.88 (95% CI, 1.312.69

doi: 10.1136/gutjnl-2012-304353 75 DickerD

The cumulative incidence of NAION over 36 months was 6.7% for the semaglutide group versus 0.8% for the non-GLP-1 RA group

These findings have provided valuable insights into the management of T2D and informed clinical practice guidelines and regulatory decisions.GLP-1 receptor agonists have emerged as an important therapeutic option for individuals with T2D, particularly those at high risk of CVD